SRI AND NON-SRI PATIENTS EXPERIENCE SIMILAR ANTIDEPRESSANT EFFECTS OF PSYCHEDELICS
A new study has shed light on the impact of psychedelics in patients taking SRIs, finding similar antidepressant effects as those not taking SRIs.
Increasing research is showing that psychedelics hold promise as potential new treatments for mental health conditions. However, how psychedelics interact with commonly prescribed antidepressants – serotonin reuptake inhibitors (SRIs) – is largely unknown.
This is a barrier to the advancement of psychedelics as mental health treatments, as those who may need these treatments the most are likely to be taking, or have taken at some point, SRIs.
Psychedelic Health takes a look at the study’s findings and speaks to researcher Tommaso Barba, PhD candidate at the Centre for Psychedelic Research, Imperial College London, to find out more.READ MORE